Insulin Lispro 100u/ml Kwikpen 3ml
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. This medication is administered via injection into the fatty layer of the skin. If you will be self-administering the injection, your doctor or nurse will provide guidance on the proper technique.
Administration Guidelines
Take the medication within 15 minutes before or immediately after a meal.
Rotate the injection site each time to avoid repeated use of the same area.
Avoid injecting into skin that is thickened, has pits or lumps, or is irritated, tender, bruised, red, scaly, hard, scarred, or has stretch marks.
Do not use the medication if the solution appears cloudy, is leaking, or contains particles, or if the solution has changed color.
Preparing the Dose
Remove all pen needle covers before injecting a dose (note that there may be two covers).
If you are unsure about the type of pen needle you have or how to use it, consult your doctor.
Be aware that the product may produce a clicking sound as you prepare the dose. However, do not rely on the clicks to determine the correct dose.
Remove the needle after each injection and do not store the device with the needle attached.
Important Safety Precautions
Do not transfer the medication from the pen to a syringe or mix it with other types of insulin.
Dispose of used needles in a designated needle/sharp disposal box. Do not reuse needles or other items.
When the disposal box is full, follow local regulations for proper disposal.
If you have any questions or concerns, consult your doctor or pharmacist.
Diet and Exercise
Follow the diet and exercise plan recommended by your doctor.
Be prepared for situations where you may not eat as much as usual or skip a meal, and know how to adjust your medication accordingly.
Storage and Disposal
Store unopened containers in the refrigerator. Do not freeze the medication, and do not use it if it has been frozen.
Missed Dose
If you forget to take a dose, be aware of the proper course of action. If you are unsure, contact your doctor for guidance.
Lifestyle & Tips
- Administer insulin exactly as prescribed by your doctor, usually 5-15 minutes before a meal or immediately after.
- Rotate injection sites within the same general area (e.g., abdomen) to prevent lipodystrophy (skin changes).
- Never share insulin pens or needles with others, even if the needle is changed, due to risk of blood-borne pathogen transmission.
- Monitor blood glucose levels regularly as instructed by your healthcare provider.
- Follow a consistent meal plan and exercise routine as advised by your doctor or dietitian.
- Always carry a source of fast-acting sugar (e.g., glucose tablets, juice) to treat mild to moderate hypoglycemia.
- Inform your healthcare provider about all medications, supplements, and herbal products you are taking.
- Store unopened pens in the refrigerator (36°F-46°F [2°C-8°C]). Once opened, store at room temperature (up to 86°F [30°C]) and use within 28 days. Do not freeze.
Available Forms & Alternatives
Available Strengths:
- Insulin Aspart 100/ml Inj,10ml
- Insulin Aspa Mix 70/30 Inj Sus 10ml
- Insulin Aspart Penfill Inj, 3ml
- Insulin Aspart Flexpen Inj, 3ml
- Insulin Aspa Mix 70/30 Flexpen, 3ml
- Insulin Lispro Junior Kwikpen 5x3ml
- Insulin Lispro Prt Mix 75/25kwikpen
- Insulin Lispro 100u/ml Vial 10ml
- Insulin Lispro 100u/ml Kwikpen 3ml
- Insulin Glarg-Yfgn 100u/ml Sol 10ml
- Insulin Glarg-Yfgn 100u/ml Pen Inj
- Insulin Glarg Solostar Pen Inj 3ml
- Insulin Glargine 100u/ml, 10ml
- Insulin Degludec U100 Inj Vial 10ml
- Insuln Glargne Solstr U300 PN 1.5ml
- Insulin Glarg U300 Max Solstr Inj
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical help right away:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Note: In rare cases, allergic reactions can be fatal.
Signs of low potassium levels, including:
+ Muscle pain or weakness
+ Muscle cramps
+ An irregular heartbeat
Signs of infection, such as:
+ Fever
+ Chills
+ Severe sore throat
+ Ear or sinus pain
+ Cough
+ Increased or discolored sputum
+ Painful urination
+ Mouth sores
+ Wounds that won't heal
Local reactions at the injection site, including:
+ Thick skin
+ Pits or lumps
Swelling in the arms or legs
Low blood sugar, which may cause:
+ Dizziness or fainting
+ Blurred vision
+ Mood changes
+ Slurred speech
+ Headache
+ Fatigue or weakness
+ Shaking
+ Rapid heartbeat
+ Confusion
+ Hunger
+ Sweating
+ Seizures
If you experience any of these symptoms, contact your doctor immediately. If you have low blood sugar, follow your doctor's instructions, which may include taking glucose tablets, liquid glucose, or consuming certain fruit juices.
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or persist, contact your doctor:
Weight gain
Flu-like symptoms
Nose or throat irritation
Common cold symptoms
Headache
Cough
Upset stomach
Stomach pain or diarrhea
Fatigue or weakness
* Irritation at the injection site
This is not an exhaustive list of possible side effects. If you have questions or concerns, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Symptoms of severe hypoglycemia (e.g., confusion, seizures, loss of consciousness) require immediate medical attention.
- Symptoms of hyperglycemia (e.g., excessive thirst, frequent urination, fatigue, blurred vision) indicate high blood sugar and may require dose adjustment.
- Signs of allergic reaction (e.g., rash, itching, hives, swelling of face/lips/tongue, difficulty breathing) require immediate medical attention.
- Symptoms of heart failure (e.g., unusual weight gain, swelling in ankles/feet, shortness of breath) if taking with TZDs.
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the symptoms you experienced as a result of the allergy.
If you have low blood sugar (hypoglycemia).
This medication may interact with other medications or health conditions. To ensure your safety, it is crucial to provide your doctor and pharmacist with a comprehensive list of:
All prescription and over-the-counter (OTC) medications you are taking
Any natural products or vitamins you are using
* Your existing health problems
Before starting, stopping, or changing the dose of any medication, including this one, consult with your doctor to confirm it is safe to do so. This will help prevent potential interactions and ensure the safe use of this medication.
Precautions & Cautions
When taking this drug, you are at risk for low blood sugar (hypoglycemia), which can lead to severe complications, including seizures, loss of consciousness, permanent brain damage, and even death. It is crucial to discuss this risk with your doctor. Additionally, this medication may cause low blood potassium (hypokalemia), which, if left untreated, can result in abnormal heart rhythms, severe breathing difficulties, and potentially be fatal. If you experience any symptoms, consult your doctor promptly.
Until you understand how this medication affects you, avoid driving and other activities that require your full attention. Certain diabetes medications, such as pioglitazone or rosiglitazone, may increase the risk of heart failure or worsen existing heart failure, especially when combined with insulin. If you are taking one of these medications, consult your doctor to discuss the potential risks.
To ensure safe use, verify that you have the correct insulin product and are familiar with its administration. Insulin products are available in various containers, including vials, cartridges, and pens. If you have any questions or concerns about measuring or preparing your dose, contact your doctor or pharmacist.
During periods of stress, such as illness, infection, injury, or surgery, your blood sugar levels may be more challenging to control. Changes in physical activity, exercise, or diet can also impact your blood sugar levels.
For your safety, wear a medical alert identification (ID) that indicates your condition. If you have experienced low blood sugar, do not drive, as this increases your risk of being involved in an accident. Monitor your blood sugar levels as directed by your doctor and undergo regular blood tests as scheduled.
Before consuming alcohol or using products containing alcohol, consult your doctor to discuss potential risks. Never share your insulin product, including pens, cartridge devices, needles, or syringes, with another person, even if the needle has been changed, as this can transmit infections.
If you are 65 or older, use this medication with caution, as you may be more susceptible to side effects. Inform your doctor if you are pregnant, plan to become pregnant, or are breastfeeding, as you will need to discuss the benefits and risks of this medication for both you and your baby.
Overdose Information
Overdose Symptoms:
- Hypoglycemia (mild to severe)
- Neuroglycopenic symptoms (e.g., confusion, disorientation, slurred speech, behavioral changes, seizures, coma)
- Hypokalemia (rare, but possible with severe overdose)
What to Do:
For mild hypoglycemia, consume fast-acting carbohydrates (e.g., glucose tablets, juice). For severe hypoglycemia, administer glucagon (if available and trained) or seek immediate medical attention. Call 911 or 1-800-222-1222 (Poison Control).
Drug Interactions
Major Interactions
- Pramlintide (increased risk of severe hypoglycemia)
- Beta-blockers (may mask symptoms of hypoglycemia)
- Thiazolidinediones (TZDs) (increased risk of fluid retention and heart failure when co-administered with insulin)
Moderate Interactions
- Oral antidiabetic agents (additive hypoglycemic effect)
- ACE inhibitors (may enhance insulin's glucose-lowering effect)
- Angiotensin Receptor Blockers (ARBs) (may enhance insulin's glucose-lowering effect)
- Salicylates (e.g., aspirin) (may enhance insulin's glucose-lowering effect)
- Sulfonamide antibiotics (may enhance insulin's glucose-lowering effect)
- Monoamine Oxidase Inhibitors (MAOIs) (may enhance insulin's glucose-lowering effect)
- Alcohol (may potentiate or diminish insulin's glucose-lowering effect)
- Corticosteroids (may decrease insulin's glucose-lowering effect)
- Diuretics (e.g., thiazides, loop diuretics) (may decrease insulin's glucose-lowering effect)
- Sympathomimetics (e.g., epinephrine, albuterol) (may decrease insulin's glucose-lowering effect)
- Growth hormone (may decrease insulin's glucose-lowering effect)
- Danazol (may decrease insulin's glucose-lowering effect)
- Oral contraceptives (may decrease insulin's glucose-lowering effect)
- Thyroid hormones (may decrease insulin's glucose-lowering effect)
- Atypical antipsychotics (e.g., olanzapine, clozapine) (may decrease insulin's glucose-lowering effect)
Monitoring
Baseline Monitoring
Rationale: To establish baseline glycemic control and set treatment goals.
Timing: Prior to initiation of therapy
Rationale: To establish baseline glucose levels.
Timing: Prior to initiation of therapy
Rationale: To assess kidney function, as insulin clearance can be affected by renal impairment.
Timing: Prior to initiation of therapy
Rationale: To assess liver function, as insulin metabolism can be affected by hepatic impairment.
Timing: Prior to initiation of therapy
Routine Monitoring
Frequency: Multiple times daily (e.g., pre-meal, 1-2 hours post-meal, bedtime, overnight as needed)
Target: Individualized, typically 80-130 mg/dL pre-meal, <180 mg/dL post-meal
Action Threshold: Hypoglycemia (<70 mg/dL) or hyperglycemia (>180-250 mg/dL depending on target)
Frequency: Every 3-6 months
Target: Individualized, typically <7%
Action Threshold: >7% (consider dose adjustment or therapy change)
Frequency: Regularly (e.g., monthly or quarterly)
Target: Maintain healthy weight
Action Threshold: Significant unexplained weight gain or loss
Frequency: Daily, with each dose and throughout the day
Target: Absence of symptoms
Action Threshold: Presence of symptoms (e.g., sweating, tremor, confusion, hunger)
Symptom Monitoring
- Symptoms of hypoglycemia (e.g., sweating, tremor, palpitations, anxiety, hunger, confusion, dizziness, headache, blurred vision, slurred speech, irritability, mood changes, unsteadiness, seizures, unconsciousness)
- Symptoms of hyperglycemia (e.g., increased thirst, increased urination, fatigue, blurred vision, unexplained weight loss)
- Injection site reactions (e.g., redness, swelling, itching, pain, lipodystrophy)
Special Patient Groups
Pregnancy
Insulin is the preferred treatment for managing diabetes in pregnant women. Available data from published studies and postmarketing reports of insulin use in pregnant women have not identified a drug-associated risk of major birth defects, miscarriage, or adverse maternal or fetal outcomes. Tight glycemic control is crucial during pregnancy to reduce risks to both mother and fetus.
Trimester-Specific Risks:
Lactation
Insulin is considered compatible with breastfeeding. Insulin is a normal component of human milk and is not orally absorbed by the infant. No adverse effects on the breastfed infant are expected. Maternal insulin requirements may change during lactation.
Pediatric Use
Insulin Lispro is safe and effective for use in pediatric patients with diabetes mellitus. Dosing must be individualized based on age, weight, and metabolic needs, with careful monitoring to prevent hypoglycemia.
Geriatric Use
Use with caution in elderly patients due to increased susceptibility to hypoglycemia, potential for renal/hepatic impairment, and comorbidities. Start with lower doses and titrate carefully. Monitor blood glucose more frequently.
Clinical Information
Clinical Pearls
- Insulin Lispro is a rapid-acting insulin, meaning it starts working quickly and has a short duration. It's crucial to administer it close to mealtime (5-15 minutes before or immediately after) to match the glucose rise from food.
- Always verify the insulin type (rapid, short, intermediate, long-acting) before administration to avoid dosing errors.
- Educate patients on proper injection technique, site rotation, and safe disposal of needles/pens.
- Stress the importance of consistent carbohydrate intake and meal timing when using mealtime insulin to prevent hypoglycemia.
- Patients should be advised to carry a source of fast-acting carbohydrates for hypoglycemia treatment.
- Be aware of factors that can affect insulin absorption (e.g., injection site, temperature, exercise).
Alternative Therapies
- Other rapid-acting insulins (e.g., Insulin Aspart, Insulin Glulisine, faster-acting Insulin Aspart, ultra-rapid Insulin Lispro)
- Short-acting insulins (e.g., Regular Human Insulin)
- Intermediate-acting insulins (e.g., NPH Human Insulin)
- Long-acting insulins (e.g., Insulin Glargine, Insulin Detemir, Insulin Degludec)
- Oral antidiabetic agents (e.g., Metformin, Sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors, GLP-1 receptor agonists) for Type 2 Diabetes.